367 related articles for article (PubMed ID: 17619840)
1. [Pharmacotherapy of schizophrenia and comorbid substance use disorder. A systematic review].
Wobrock T; D'Amelio R; Falkai P
Nervenarzt; 2008 Jan; 79(1):17-8, 20-2, 24-6 passim. PubMed ID: 17619840
[TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy of schizophrenia with comorbid substance use disorder--reviewing the evidence and clinical recommendations.
Wobrock T; Soyka M
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1375-85. PubMed ID: 18394768
[TBL] [Abstract][Full Text] [Related]
3. Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches.
Green AI
J Clin Psychiatry; 2006; 67 Suppl 7():31-5; quiz 36-7. PubMed ID: 16961422
[TBL] [Abstract][Full Text] [Related]
4. Pharmacotherapy of patients with schizophrenia and substance abuse.
Wobrock T; Soyka M
Expert Opin Pharmacother; 2009 Feb; 10(3):353-67. PubMed ID: 19191675
[TBL] [Abstract][Full Text] [Related]
5. Naltrexone and disulfiram in patients with alcohol dependence and current depression.
Petrakis I; Ralevski E; Nich C; Levinson C; Carroll K; Poling J; Rounsaville B;
J Clin Psychopharmacol; 2007 Apr; 27(2):160-5. PubMed ID: 17414239
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders.
San L; Arranz B; Martinez-Raga J
Eur Addict Res; 2007; 13(4):230-43. PubMed ID: 17851245
[TBL] [Abstract][Full Text] [Related]
7. Current status of co-occurring mood and substance use disorders: a new therapeutic target.
Pettinati HM; O'Brien CP; Dundon WD
Am J Psychiatry; 2013 Jan; 170(1):23-30. PubMed ID: 23223834
[TBL] [Abstract][Full Text] [Related]
8. Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram.
Petrakis IL; Nich C; Ralevski E
Schizophr Bull; 2006 Oct; 32(4):644-54. PubMed ID: 16887890
[TBL] [Abstract][Full Text] [Related]
9. Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders.
Petrakis IL; Poling J; Levinson C; Nich C; Carroll K; Rounsaville B;
Biol Psychiatry; 2005 May; 57(10):1128-37. PubMed ID: 15866552
[TBL] [Abstract][Full Text] [Related]
10. [Depression in alcohol addicted patients].
Ponizovskiy PA; Gofman AG
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(7):146-150. PubMed ID: 26356528
[TBL] [Abstract][Full Text] [Related]
11. Substance abuse and schizophrenia: pharmacotherapeutic intervention.
Green AI; Noordsy DL; Brunette MF; O'Keefe C
J Subst Abuse Treat; 2008 Jan; 34(1):61-71. PubMed ID: 17574793
[TBL] [Abstract][Full Text] [Related]
12. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
13. Treatment of dual diagnosis disorders.
Murthy P; Chand P
Curr Opin Psychiatry; 2012 May; 25(3):194-200. PubMed ID: 22395768
[TBL] [Abstract][Full Text] [Related]
14. Randomized Trial of the Effect of Four Second-Generation Antipsychotics and One First-Generation Antipsychotic on Cigarette Smoking, Alcohol, and Drug Use in Chronic Schizophrenia.
Mohamed S; Rosenheck RA; Lin H; Swartz M; McEvoy J; Stroup S
J Nerv Ment Dis; 2015 Jul; 203(7):486-92. PubMed ID: 26075840
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, acceptability and tolerability of antipsychotics in patients with schizophrenia and comorbid substance use. A systematic review and meta-analysis.
Krause M; Huhn M; Schneider-Thoma J; Bighelli I; Gutsmiedl K; Leucht S
Eur Neuropsychopharmacol; 2019 Jan; 29(1):32-45. PubMed ID: 30472164
[TBL] [Abstract][Full Text] [Related]
16. Schizophrenia and comorbid substance use disorder: effects of antipsychotics.
Green AI
J Clin Psychiatry; 2005; 66 Suppl 6():21-6. PubMed ID: 16107180
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological treatment of schizophrenia with comorbid substance use disorder.
Azorin JM; Simon N; Adida M; Belzeaux R
Expert Opin Pharmacother; 2016; 17(2):231-53. PubMed ID: 26635059
[TBL] [Abstract][Full Text] [Related]
18. Clozapine use in patients with schizophrenia and a comorbid substance use disorder: A systematic review.
Arranz B; Garriga M; García-Rizo C; San L
Eur Neuropsychopharmacol; 2018 Feb; 28(2):227-242. PubMed ID: 29273271
[TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapy of alcohol dependence: a review of the clinical data.
Mann K
CNS Drugs; 2004; 18(8):485-504. PubMed ID: 15182219
[TBL] [Abstract][Full Text] [Related]
20. Schizophrenia and co-occurring substance use disorder.
Green AI; Drake RE; Brunette MF; Noordsy DL
Am J Psychiatry; 2007 Mar; 164(3):402-8. PubMed ID: 17329463
[No Abstract] [Full Text] [Related]
[Next] [New Search]